Difference between revisions of "Tamoxifen (Nolvadex)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 1: Line 1:
Also known as Istubal, Soltamox, or Valodex.
 
 
 
==General information==
 
==General information==
 
Class/mechanism: SERM (selective estrogen receptor modulator), with estrogen agonist/antagonist properties depending on tissue type. Tamoxifen has estrogen antagonist properties in breast tissue. It has estrogen agonist properties in bone, helping to decrease bone resorption, but in contrast to [[Raloxifene (Evista)]], it also has agonist properties in uterine tissue.<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/17970s053lbl.pdf Tamoxifen (Nolvadex) package insert]</ref><ref>[[Media:Tamoxifen.pdf | Tamoxifen (Nolvadex) package insert (locally hosted backup)]]</ref>
 
Class/mechanism: SERM (selective estrogen receptor modulator), with estrogen agonist/antagonist properties depending on tissue type. Tamoxifen has estrogen antagonist properties in breast tissue. It has estrogen agonist properties in bone, helping to decrease bone resorption, but in contrast to [[Raloxifene (Evista)]], it also has agonist properties in uterine tissue.<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/17970s053lbl.pdf Tamoxifen (Nolvadex) package insert]</ref><ref>[[Media:Tamoxifen.pdf | Tamoxifen (Nolvadex) package insert (locally hosted backup)]]</ref>
Line 16: Line 14:
 
*[http://chemocare.com/chemotherapy/drug-info/Tamoxifen.aspx Tamoxifen (Nolvadex) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/Tamoxifen.aspx Tamoxifen (Nolvadex) patient drug information (Chemocare)]</ref>
 
*[http://chemocare.com/chemotherapy/drug-info/Tamoxifen.aspx Tamoxifen (Nolvadex) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/Tamoxifen.aspx Tamoxifen (Nolvadex) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/tamoxifen-patient-drug-information Tamoxifen (Nolvadex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/tamoxifen-patient-drug-information Tamoxifen (Nolvadex) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/tamoxifen-patient-drug-information Tamoxifen (Nolvadex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/tamoxifen-patient-drug-information Tamoxifen (Nolvadex) patient drug information (UpToDate)]</ref>
 +
 +
==Also known as==
 +
*'''Brand names:''' Istubal, Nolvadex, Soltamox, Valodex
  
 
==References==
 
==References==
Line 21: Line 22:
  
 
[[Category:Drug index]]
 
[[Category:Drug index]]
 +
[[Category:Oral medications]]
 +
[[Category:Protein expression-specific medications]]
 +
 
[[Category:Selective estrogen receptor modulators]]
 
[[Category:Selective estrogen receptor modulators]]
 
[[Category:Breast cancer medications]]
 
[[Category:Breast cancer medications]]

Revision as of 16:45, 1 November 2017

General information

Class/mechanism: SERM (selective estrogen receptor modulator), with estrogen agonist/antagonist properties depending on tissue type. Tamoxifen has estrogen antagonist properties in breast tissue. It has estrogen agonist properties in bone, helping to decrease bone resorption, but in contrast to Raloxifene (Evista), it also has agonist properties in uterine tissue.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

Also known as

  • Brand names: Istubal, Nolvadex, Soltamox, Valodex

References